Contact
searchSearch
HMP Global

Volume 16 - Issue 9 - September 2008

Derm Dx
What Caused this Tender Skin Eruption?
09/22/2008
Patient Presentation A 40-year-old African-American woman presented with widespread tender, brown-grey plaques with red borders that developed over 2 days. The lesions spared her mucosal and palmoplantar areas. The only positive review of...
Patient Presentation A 40-year-old African-American woman presented with widespread tender, brown-grey plaques with red borders that developed over 2 days. The lesions spared her mucosal and palmoplantar areas. The only positive review of...
Patient Presentation A...
09/22/2008
The Dermatologist
Feature Story
Skincare Regimens to Optimize Laser Success
09/22/2008
Tailoring your treatment regimens to each patient before and after laser resurfacing can be as important as the technology you choose in striving to help patients recapture the more youthful appearance they seek.
Tailoring your treatment regimens to each patient before and after laser resurfacing can be as important as the technology you choose in striving to help patients recapture the more youthful appearance they seek.
Tailoring your treatment...
09/22/2008
The Dermatologist
Kindling Midlife Fires: Advice on staying motivated and avoiding burnout, and the crucial role dermatologists play in helping pa
09/22/2008
What is midlife? What are we to expect during our passage through this life phase? Arguably, the mid-life period spans from as brief a period as ages 45 to 64 to as long a span as ages 30 to 60. What are the hallmarks that characterize these...
What is midlife? What are we to expect during our passage through this life phase? Arguably, the mid-life period spans from as brief a period as ages 45 to 64 to as long a span as ages 30 to 60. What are the hallmarks that characterize these...
What is midlife? What are we to...
09/22/2008
The Dermatologist
Lidocaine Release Faster with Topical Foam Compared to Cream Formulation
09/22/2008
A poster sponsored by Onset Therapeutics (Cumberland, RI) demonstrated that its lidocaine 4% topical foam, Anestafoam, delivers pain relief more quickly than Lidocaine 4% Topical Cream LMX4 (Ferndale Laboratories,Inc., Ferndale, MI), and...
A poster sponsored by Onset Therapeutics (Cumberland, RI) demonstrated that its lidocaine 4% topical foam, Anestafoam, delivers pain relief more quickly than Lidocaine 4% Topical Cream LMX4 (Ferndale Laboratories,Inc., Ferndale, MI), and...
A poster sponsored by Onset...
09/22/2008
The Dermatologist
MOSAIC Fractional Laser System ‘Spray Paints’ Damaged Skin
09/22/2008
Said to be flexible and precise, the MOSAIC fractional laser system from Lutronic USA (Princeton Junction, NJ) is designed for a variety of aesthetic and dermatological applications, including scarring, sun-damaged skin and skin...
Said to be flexible and precise, the MOSAIC fractional laser system from Lutronic USA (Princeton Junction, NJ) is designed for a variety of aesthetic and dermatological applications, including scarring, sun-damaged skin and skin...
Said to be flexible and precise,...
09/22/2008
The Dermatologist
Fractionated DOT Therapy Enable CO2 Laser Treatment of Nonfacial Skin
09/22/2008
Dermal Optical Thermolysis (DOT) — CO2 technology that ablates a customized pattern of dots instead of the entire skin surface — has entered the U.S. market via an alliance between the U.S. laser distributor Eclipse, and DEKA, its Italian...
Dermal Optical Thermolysis (DOT) — CO2 technology that ablates a customized pattern of dots instead of the entire skin surface — has entered the U.S. market via an alliance between the U.S. laser distributor Eclipse, and DEKA, its Italian...
Dermal Optical Thermolysis (DOT)...
09/22/2008
The Dermatologist
Cutera’s 2790 nm Pearl YSGG Laser Found Safe and Effective
09/22/2008
Two studies presented as posters at the American Society for Laser Medicine and Surgery (ASLMS) meeting support the safety and efficacy claims of Cutera, Inc. (Brisbane, CA) for its 2,790 nm Pearl YSGG Laser. Assessment of the Impact of...
Two studies presented as posters at the American Society for Laser Medicine and Surgery (ASLMS) meeting support the safety and efficacy claims of Cutera, Inc. (Brisbane, CA) for its 2,790 nm Pearl YSGG Laser. Assessment of the Impact of...
Two studies presented as posters...
09/22/2008
The Dermatologist
Serenity Pro From Candela Reduces Laser and IPL Treatment Pain
09/22/2008
FDA-approved for pain reduction during laser or light-based aesthetic treatments, the Serenity Pro from Candela Corporation (Wayland, MA) uses a proprietary and patented technology called Pneumatic Skin Flattening (PSF) to reduce pain during...
FDA-approved for pain reduction during laser or light-based aesthetic treatments, the Serenity Pro from Candela Corporation (Wayland, MA) uses a proprietary and patented technology called Pneumatic Skin Flattening (PSF) to reduce pain during...
FDA-approved for pain reduction...
09/22/2008
The Dermatologist
Hand-Held Personal Laser Hair Removal System Now Available
09/22/2008
The TRIA Personal Laser Hair Removal System, the first FDA-cleared laser for at-home hair removal in the United States, can now be purchased from designated aesthetic physicians nationwide, with additional distribution in fall 2008 at select...
The TRIA Personal Laser Hair Removal System, the first FDA-cleared laser for at-home hair removal in the United States, can now be purchased from designated aesthetic physicians nationwide, with additional distribution in fall 2008 at select...
The TRIA Personal Laser Hair...
09/22/2008
The Dermatologist
Reliant’s Fraxel Laser Side Effects Assessed
09/22/2008
Investigators seeking to determine the frequency and range of side effects and complications associated with fractional photothermolysis treatment reported that the technology was effective in the treatment of photodamaged skin and scars,...
Investigators seeking to determine the frequency and range of side effects and complications associated with fractional photothermolysis treatment reported that the technology was effective in the treatment of photodamaged skin and scars,...
Investigators seeking to...
09/22/2008
The Dermatologist
Study Finds Q-Switched Nd:YAG Lasers Effective for Melasma
09/22/2008
A study of 17 patients treated with the Spectra VRM II Q-switched Nd:YAG laser (Lutronic, South Korea) deemed this treatment method — minimized selective photothermolysis — to be an effective new treatment for melasma. The technology...
A study of 17 patients treated with the Spectra VRM II Q-switched Nd:YAG laser (Lutronic, South Korea) deemed this treatment method — minimized selective photothermolysis — to be an effective new treatment for melasma. The technology...
A study of 17 patients treated...
09/22/2008
The Dermatologist
Skin Tightening Technologies: Comparing and Contrasting Available Technologies
09/22/2008
Skin tightening technologies have become some of the most popular aesthetic cosmetic procedures being performed in the laser world today. Nearly every laser company has a skin tightening device available for laser surgeons worldwide. This...
Skin tightening technologies have become some of the most popular aesthetic cosmetic procedures being performed in the laser world today. Nearly every laser company has a skin tightening device available for laser surgeons worldwide. This...
Skin tightening technologies...
09/22/2008
The Dermatologist
Legal Ease
Updates on Yesterday’s News
09/22/2008
Over the last 4 years of writing this column, I have covered dozens of issues in healthcare law. In this month’s column, I revisit three issues I addressed previously to update our readers on the state of those laws in 2008. They include: (1)...
Over the last 4 years of writing this column, I have covered dozens of issues in healthcare law. In this month’s column, I revisit three issues I addressed previously to update our readers on the state of those laws in 2008. They include: (1)...
Over the last 4 years of writing...
09/22/2008
The Dermatologist
Alternative Treatment for Seborrheic Dermatitis
09/22/2008
Natural therapies for seborrheic dermatitis, such as tea tree oil, essential fatty acids, nutritional supplements and homeopathic and holistic treatments, are becoming more and more popular with patients as they may not be satisfied with...
Natural therapies for seborrheic dermatitis, such as tea tree oil, essential fatty acids, nutritional supplements and homeopathic and holistic treatments, are becoming more and more popular with patients as they may not be satisfied with...
Natural therapies for seborrheic...
09/22/2008
The Dermatologist
Ethnic Skin and Hair
Lasers in Ethnic Skin
09/22/2008
The use of lasers in ethnic skin can pose a therapeutic challenge due to significant risks of post-inflammatory pigment alteration in this patient population. The greatest risk occurs in lasers with wavelengths in the range of the absorption...
The use of lasers in ethnic skin can pose a therapeutic challenge due to significant risks of post-inflammatory pigment alteration in this patient population. The greatest risk occurs in lasers with wavelengths in the range of the absorption...
The use of lasers in ethnic skin...
09/22/2008
The Dermatologist
Allergen Focus
Focus On: COCAMIDE DEA (COCAMIDE DIETHANOLAMINE)
09/22/2008
In 1997 the Food and Drug Administration gave indication to the Thin-layer Rapid-Use Epicutaneous (T.R.U.E.) test for use as a “valuable,” first-line screening tool in the diagnosis of allergic contact dermatitis (ACD). Many dermatologists...
In 1997 the Food and Drug Administration gave indication to the Thin-layer Rapid-Use Epicutaneous (T.R.U.E.) test for use as a “valuable,” first-line screening tool in the diagnosis of allergic contact dermatitis (ACD). Many dermatologists...
In 1997 the Food and Drug...
09/22/2008
The Dermatologist
Spotlight
SPOTLIGHT on Harold J. Brody, MD
09/22/2008
Dr. Harold J. Brody is Clinical Professor of Dermatology at Emory University School of Medicine in Atlanta, GA. He has done extensive work in the field of skin rejuvenation, having devised the technique for and having coined the term,...
Dr. Harold J. Brody is Clinical Professor of Dermatology at Emory University School of Medicine in Atlanta, GA. He has done extensive work in the field of skin rejuvenation, having devised the technique for and having coined the term,...
Dr. Harold J. Brody is Clinical...
09/22/2008
The Dermatologist
Certification Exam for Nurse Practitioners in Dermatology Now Available
09/22/2008
The Dermatology Nursing Certification Board (DNCB) is now offering a certification exam for nurse practitioners in dermatology. The first DNCB exam was offered in March 2008 and in the future is scheduled to be held three times each year....
The Dermatology Nursing Certification Board (DNCB) is now offering a certification exam for nurse practitioners in dermatology. The first DNCB exam was offered in March 2008 and in the future is scheduled to be held three times each year....
The Dermatology Nursing...
09/22/2008
The Dermatologist
Medical School Survey Flags Conflict of Interest Practices
09/22/2008
According to the American Medical Student Association, which has ranked U.S. medical schools according to conflict of interest policies related to money, gifts, and free samples offered by pharmaceutical companies, most need to revise and...
According to the American Medical Student Association, which has ranked U.S. medical schools according to conflict of interest policies related to money, gifts, and free samples offered by pharmaceutical companies, most need to revise and...
According to the American...
09/22/2008
The Dermatologist
New Survey Finds Most Mothers may Overlook Severe Cases of Diaper Rash
09/22/2008
A survey of new and expectant mothers found that new mothers consider their pediatricians — less than friends, the internet and their own mothers — to be their most trusted sources of information on child care issues, such as diaper...
A survey of new and expectant mothers found that new mothers consider their pediatricians — less than friends, the internet and their own mothers — to be their most trusted sources of information on child care issues, such as diaper...
A survey of new and expectant...
09/22/2008
The Dermatologist
Melanoma Group Counters Tanning Industry Message on Benefits of Sun Exposure
09/22/2008
According to information provided by the Melanoma Research Foundation (MRF), the health benefits of vitamin D — which can be gotten safely from diet and supplements — through sunlight exposure are greatly outweighed by the risks associated...
According to information provided by the Melanoma Research Foundation (MRF), the health benefits of vitamin D — which can be gotten safely from diet and supplements — through sunlight exposure are greatly outweighed by the risks associated...
According to information...
09/22/2008
The Dermatologist
News
Renovo Announces Results of Phase II Scar Treatment Study
09/22/2008
Renovo’s Phase II trial for Juvista in scar revision surgery has met its primary endpoint. The randomized, double-blind, placebo-controlled study investigated the safety and efficacy of Juvista given at the time of surgery following wound...
Renovo’s Phase II trial for Juvista in scar revision surgery has met its primary endpoint. The randomized, double-blind, placebo-controlled study investigated the safety and efficacy of Juvista given at the time of surgery following wound...
Renovo’s Phase II trial for...
09/22/2008
The Dermatologist
News
LEO Pharma’s Drug for the Treatment of Scalp Psoriasis Approved in Europe
09/22/2008
LEO Pharma’s new drug for treatment of scalp psoriasis, Xamiol, has been approved in 16 European countries. The UK will be the first country to market Xamiol. In extensive clinical studies, Xamiol has proved to be a very efficient drug in the...
LEO Pharma’s new drug for treatment of scalp psoriasis, Xamiol, has been approved in 16 European countries. The UK will be the first country to market Xamiol. In extensive clinical studies, Xamiol has proved to be a very efficient drug in the...
LEO Pharma’s new drug for...
09/22/2008
The Dermatologist
News
Galderma Announces Approval for Differin Gel 0.1% in Japan
09/22/2008
Galderma recently announced that Japan’s Ministry of Health, Labor and Welfare has approved adapalene (Differin Gel 0.1%), a novel topical treatment for acne vulgaris. The drug will be marketed in Japan by Galderma KK, the fully-owned...
Galderma recently announced that Japan’s Ministry of Health, Labor and Welfare has approved adapalene (Differin Gel 0.1%), a novel topical treatment for acne vulgaris. The drug will be marketed in Japan by Galderma KK, the fully-owned...
Galderma recently announced that...
09/22/2008
The Dermatologist
News
FDA Approves Generic Cefazolin for Injection
09/22/2008
The FDA approved Aurobindo Pharma’s generic version of the injectable antibiotic cefazolin made by Abraxis Pharmaceutical. Cefazolin, a cephalosporin antibiotic, is used to eliminate bacteria that cause different types of infections,...
The FDA approved Aurobindo Pharma’s generic version of the injectable antibiotic cefazolin made by Abraxis Pharmaceutical. Cefazolin, a cephalosporin antibiotic, is used to eliminate bacteria that cause different types of infections,...
The FDA approved Aurobindo...
09/22/2008
The Dermatologist
News
New Product Family of Iridex IQ Laser Systems Receives FDA Clearance
09/22/2008
Iridex Corporation recently announced its receipt of FDA 510(k) clearance for its Family of Iridex IQ Laser Systems. This clearance covers the Iridex IQ 532, IQ 577, IQ 630-670 and IQ 810 Laser Systems and their associated delivery devices to...
Iridex Corporation recently announced its receipt of FDA 510(k) clearance for its Family of Iridex IQ Laser Systems. This clearance covers the Iridex IQ 532, IQ 577, IQ 630-670 and IQ 810 Laser Systems and their associated delivery devices to...
Iridex Corporation recently...
09/22/2008
The Dermatologist
News
Manufacturers of TNF-Blocker Drugs Ordered to Highlight Risk of Fungal Infections
09/22/2008
The FDA recently announced that the manufacturers of tumor necrosis factor alpha blockers (TNF-alpha blockers) must strengthen the existing warnings about the risk of developing opportunistic fungal infections when taking these drugs. These...
The FDA recently announced that the manufacturers of tumor necrosis factor alpha blockers (TNF-alpha blockers) must strengthen the existing warnings about the risk of developing opportunistic fungal infections when taking these drugs. These...
The FDA recently announced that...
09/22/2008
The Dermatologist
Chief Medical Editor Message
Light and Laser Therapies: Tips to Optimize Treatment Success
09/22/2008
In our 10th Annual Laser Surgery Issue, we hope you’ll glean tips to enhance light and laser procedures you’re already performing or find out about a new technology that could benefit your practice. A Look at the Issue This month’s...
In our 10th Annual Laser Surgery Issue, we hope you’ll glean tips to enhance light and laser procedures you’re already performing or find out about a new technology that could benefit your practice. A Look at the Issue This month’s...
In our 10th Annual Laser Surgery...
09/22/2008
The Dermatologist
Chief Medical Editor Message
Drug Ties
09/22/2008
A March 21, 2008, New York Times article1 described some of the financial ties physicians have to drug companies. The details of some of these ties became public due to openness legislation in some states. The Minnesota Legislature passed a...
A March 21, 2008, New York Times article1 described some of the financial ties physicians have to drug companies. The details of some of these ties became public due to openness legislation in some states. The Minnesota Legislature passed a...
A March 21, 2008, New York Times...
09/22/2008
The Dermatologist

Popular Articles

Clinical Tips
Approach to Patients With Delusions of Parasitosis
02/07/2024
Benjamin Barankin, MD, FRCPC
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from dermatologic experts in mind for your next appointment.
Keep these tips and pearls from...
02/07/2024
The Dermatologist
psoriasis
News
IL-17A Inhibitors Restore Intestinal/Skin Microbiota Homeostasis and Altered Microbiota Function in Psoriasis
03/15/2024
Jessica Garlewicz
Researchers aimed to investigate the association between psoriasis and alterations in gut/skin microbiota.
Researchers aimed to investigate the association between psoriasis and alterations in gut/skin microbiota.
Researchers aimed to investigate...
03/15/2024
The Dermatologist
Cover Story
Current Trends and Future Directions in Psoriatic Disease
05/03/2024
Joseph F. Merola, MD, MMSc
National Psoriasis Foundation Commit to Cure honorees discuss treatment advances, patient advocacy work, and dermatology-rheumatology collaboration.
National Psoriasis Foundation Commit to Cure honorees discuss treatment advances, patient advocacy work, and dermatology-rheumatology collaboration.
National Psoriasis Foundation...
05/03/2024
The Dermatologist
Spotlight
A Conversation With John Barbieri, MD, MBA
06/06/2024
Benjamin Barankin, MD, FRCPC
Dr John Barbieri is an assistant professor at Harvard Medical School and the director of the Advanced Acne Therapeutics Clinic at Brigham and Women’s Hospital in Boston, MA.
Dr John Barbieri is an assistant professor at Harvard Medical School and the director of the Advanced Acne Therapeutics Clinic at Brigham and Women’s Hospital in Boston, MA.
Dr John Barbieri is an assistant...
06/06/2024
The Dermatologist
psoriasis
News
Systemic Immunity-Inflammation Index Associated With Psoriasis
06/20/2024
Jessica Garlewicz
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the association between the systemic immune-inflammatory index and psoriasis among US adult outpatients.
Researchers aimed to assess the...
06/20/2024
The Dermatologist
jan/feb issue

Current Issue

January 2026
Volume 34
Issue 1
Current Issue
Issue Archive

Latest Quizzes and Trivia

Quiz
Initiating JAK Inhibitors in AA: Screening, Safety, and Shared Decision-Making
01/15/2026
Riya Gandhi, MA
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best practices before initiating JAK inhibitors for alopecia areata.
Test your knowledge of best...
01/15/2026
The Dermatologist
Quiz
MACE Risk in Alopecia Areata: What Clinical Trials and Real-World Data Reveal
01/05/2026
Riya Gandhi, MA
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which patients experienced MACE events in clinical trials and how real-world incidence data compares.
This quiz examines which...
01/05/2026
The Dermatologist
Quiz
Why Higher JAK Doses Raise Safety Concerns in AD
01/01/2026
Riya Gandhi, MA
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can you pinpoint the molecular reason behind increased adverse event risk with high-dose JAK inhibitor therapy?
Dive into kinase dynamics—can...
01/01/2026
The Dermatologist
Quiz
What Drives Fibrosis in Chronic Atopic Dermatitis Lesions?
01/01/2026
Riya Gandhi, MA
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how fibroblasts respond to Type 2 cytokines in long-standing AD.
Take the quiz to explore how...
01/01/2026
The Dermatologist
Quiz
Alopecia Areata Support Systems, Peer Networks, and Patient Misinformation
12/20/2025
Riya Gandhi, MA
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients through peer-driven misinformation and anxiety-provoking online forums? Take this quiz to refine your approach to trusted resources and patient-centered reassurance.
How do you guide patients...
12/20/2025
The Dermatologist
acne
Quiz
Quiz: Acne Topical Therapy
12/18/2025
Jessica Garlewicz
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical acne therapy was highlighted as improving tolerability while maintaining efficacy?
Which advancement in topical...
12/18/2025
The Dermatologist
psoriasis
Quiz
Quiz: Clinical Clue in Psoriasis Diagnosis
12/18/2025
Jessica Garlewicz
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt a dermatologist to question the diagnosis of psoriasis, especially when highly effective agents fail?
What clinical clue should prompt...
12/18/2025
The Dermatologist
Quiz
Etiological Communication, Atopy, and First-Visit Navigation in AA
12/10/2025
Riya Gandhi, MA
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit conversation for AA patients. Quiz yourself on how to balance hope with realism, address comorbid atopy, and respond to the quest for deeper causality in autoimmune disease.
Master the first-visit...
12/10/2025
The Dermatologist
Quiz
Clinical Benefit of Accurate Risk Stratification in cSCC Management
12/04/2025
Jessica Garlewicz
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical benefit of accurate risk stratification in cutaneous squamous cell carcinoma management?
What is the primary clinical...
12/04/2025
The Dermatologist
Quiz
Investigative Urgency and Autoimmune Framing in AA
12/01/2025
Riya Gandhi, MA
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive testing to “find the root cause” of AA. Take this quiz to sharpen your ability to guide these discussions.
Patients often seek extensive...
12/01/2025
The Dermatologist

September 2008 Issue 9

View Issue Archive
Editorial Correspondence

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use